Clinical Trials

Showing 133–144 of 146 results

  • Select options This product has multiple variants. The options may be chosen on the product page

    Optimizing Patient Recruitment in Clinical Trials

    $2,460.00$4,920.00
  • Select options This product has multiple variants. The options may be chosen on the product page

    CRO Quality Benchmarking – Phase II/III Service Providers (4th edition)

    $6,800.00$13,600.00
  • Select options This product has multiple variants. The options may be chosen on the product page

    Optimizing Feasibility in Clinical Trials

    $2,460.00$4,920.00
  • Select options This product has multiple variants. The options may be chosen on the product page

    Post-marketing Safety Market Overview and Outlook

    $4,900.00$7,350.00
  • Select options This product has multiple variants. The options may be chosen on the product page

    The Phase I Market Overview and Outlook

    $4,900.00$7,350.00
  • Select options This product has multiple variants. The options may be chosen on the product page

    CRO Quality Benchmarking Report (3rd edition)

    $6,800.00$10,200.00
  • Select options This product has multiple variants. The options may be chosen on the product page

    CRO Selection for Small Pharma and Biotech (2011)

    $2,460.00$3,690.00
  • Select options This product has multiple variants. The options may be chosen on the product page

    EDC and ePRO Market Overview and Outlook

    $4,900.00$7,350.00
  • Select options This product has multiple variants. The options may be chosen on the product page

    Improving Patient Recruitment and Feasibility: Recommendations from Site Coordinators

    $4,900.00$7,350.00
  • Select options This product has multiple variants. The options may be chosen on the product page

    The State of the Central Lab Market

    $2,460.00$3,690.00
  • Select options This product has multiple variants. The options may be chosen on the product page

    CRO Quality Benchmarking (2nd edition)

    $6,800.00$10,200.00
  • Select options This product has multiple variants. The options may be chosen on the product page

    Late Phase Market Overview and Outlook (2010)

    $6,800.00$10,200.00